BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krastev Z, Koltchakov V, Tomova R, Deredjian S, Alexiev A, Popov D, Tomov B, Koten JW, Jacobs J, Otter WD. Locoregional IL-2 low dose applications for gastrointestinal tumors. World J Gastroenterol 2005; 11(35): 5525-5529 [PMID: 16222748 DOI: 10.3748/wjg.v11.i35.5525]
URL: https://www.wjgnet.com/1007-9327/full/v11/i35/5525.htm
Number Citing Articles
1
Suyog Shaha, Danika Rodrigues, Samir Mitragotri. Locoregional drug delivery for cancer therapy: Preclinical progress and clinical translationJournal of Controlled Release 2024; 367: 737 doi: 10.1016/j.jconrel.2024.01.072
2
Cong-Jun Wang, Chao Wang, Jiang Han, Yong-Kun Wang, Lin Tang, Dong-Wei Shen, Yi Zhao, Rong-Hua Xu, Hui Zhang. Effect of combined treatment with recombinant interleukin-2 and allicin on pancreatic cancerMolecular Biology Reports 2013; 40(12): 6579 doi: 10.1007/s11033-013-2766-1
3
Mohamed A. Shaker, Husam M. Younes. Interleukin-2: Evaluation of Routes of Administration and Current Delivery Systems in Cancer TherapyJournal of Pharmaceutical Sciences 2009; 98(7): 2268 doi: 10.1002/jps.21596
4
Lindsay Kathleen Dickerson, Jason A Carter, Karan Kohli, Venu G Pillarisetty. Emerging interleukin targets in the tumour microenvironment: implications for the treatment of gastrointestinal tumoursGut 2023; 72(8): 1592 doi: 10.1136/gutjnl-2023-329650
5
Willem Den Otter, John J. L. Jacobs, Jan J. Battermann, Gerrit Jan Hordijk, Zachary Krastev, Ekaterina V. Moiseeva, Rachel J. E. Stewart, Paul G. P. M. Ziekman, Jan Willem Koten. Local therapy of cancer with free IL-2Cancer Immunology, Immunotherapy 2008; 57(7): 931 doi: 10.1007/s00262-008-0455-z